Prostate Carcinoma Psa Level
The prostate specific antigen or PSA test is an important test to detect prostate cancer, as well as monitor the progress of prostate cancer treatment.
The prostate specific antigen blood test measures a protein that is made by the prostate gland. PSA is increased in males who have prostate cancer.
A normal PSA level is lower than 4 nanograms per milliliter (ng/ml). About one-quarter of men with borderline PSA elevations (4.1 to 10.0 ng/ml) have prostate cancer. Almost two-thirds of those with PSA levels of 10 ng/ml, or higher, have prostate cancer. Very high PSA levels suggest the presence of advanced cancer.
PSA testing is recommended annually for all men over the age of 50. If you are under 50 years old, your doctor can decide whether you require PSA testing.
Additional testing for prostate cancer may be required in the following situations:
Continue to Prostate Carcinoma Staging
- Alibhai SM, Klotz LH. A systematic review of randomized trials in localized prostate cancer. Can J Urol. 2004 Feb;11(1):2110-7. 
- Astorg P. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control. 2004 May;15(4):367-86. 
- Dagnelie PC, Schuurman AG, Goldbohm RA, Van den Brandt PA. Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int. 2004 May;93(8):1139-50. 
- Johns LE, Houlston RS. A systematic review and meta-analysis of familial prostate cancer risk. BJU Int. 2003 Jun;91(9):789-94. 
- Mahmud S, Franco E, Aprikian A. Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis. Br J Cancer. 2004 Jan 12;90(1):93-9.